The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic neuropathy.

More than 450 million people worldwide suffer from diabetes, or 1 in 11 people. Chronic hyperglycemia degrades patients' quality of life and the development of neuropathic pain contributes to the burden of this disease. In this study, we used the mouse model of streptozocin-induced diabetic typ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/b600b610af8d4133a6f1ddeb47c164d9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!